Acne vulgaris, better known as acne, is the most common skin condition in the US, according to the American Academy of Dermatology (AAD), affecting up to 50 million Americans annually. About 85% of ...

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer has completed a Phase 1 trial titled “A Phase 1, Randomized, ...

Acne is the most common skin condition in the United States and its effects can be devastating. However, successful treatment can be hard to come by. "I have had problems with my skin for as long as I ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Previous associations between depression, suicidal behavior and the acne drug isotretinoin may be explained by presence of the acne itself, rather than treatment with the medication, according to ...

--The Phase III clinical trial of ASC40 for moderate to severe acne vulgaris will enroll 480 subjects --The protocol of Phase III clinical trial has been agreed by Center for Drug Evaluation, National ...

Among nearly 20 different agents and treatment combinations, topical triple-agent fixed-dose combination (FDC) gel emerged as the most efficacious for moderate-to-severe acne. Researchers who ...

Although many topical or systemic antibiotics exist to treat acne vulgaris, the common inflammatory skin disease is not fully treatable. A new article published in The Journal of Clinical and ...

NEWARK, Del, Aug. 15, 2023 (GLOBE NEWSWIRE) -- The Moderate-to-Severe Acne Treatment Market has witnessed significant growth in recent years, driven by the increasing prevalence of acne and the ...